EquityPanditβs Outlook for Lupin for the weekΒ Β (July 30, 2018Β βΒ Aug 03, 2018) :Β LUPIN: Lupin closed the week on positive note gaining around 1.80%....
Lupin has launched Desoximetasone Topical Spray, in the US market. It is used for treatment of plaque psoriasis. In a regulatory filing the company stated,...
EquityPanditβs Outlook for Lupin for the weekΒ Β (July 16, 2018Β βΒ July 20, 2018) :Β LUPIN: Lupin closed the week on negative note losing around 7.50%....
LupinΒ has received approval from the UK health regulator its Goa facility. In a regulatory filing the company stated that, itΒ has received approval from UK MHRA...
EquityPanditβs Outlook for Lupin for the weekΒ Β (July 16, 2018Β βΒ July 20, 2018) :Β LUPIN: Lupin closed the week on negative note losing around 5.50%....
EquityPanditβs Outlook for Lupin for the weekΒ Β (July 09, 2018Β βΒ July 13, 2018) :Β LUPIN: Lupin closed the week on positive note gaining around 1.30%....
EquityPanditβs Outlook for Lupin for the weekΒ Β (July 02, 2018Β βΒ July 06, 2018) :Β LUPIN: Lupin closed the week on absolutely flat note. As we...
Lupin has associatedΒ with Mylan to commercialize Enbrel biosimilar. Enbrel is a TNF-inhibitoriΒ suggested to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis and...
EquityPanditβs Outlook for Lupin for the weekΒ Β (June 25, 2018Β βΒ June 29, 2018) :Β LUPIN: Lupin closed the week on negative note losing around 1.10%....
EquityPanditβs Outlook for Lupin for the weekΒ Β (June 18, 2018Β βΒ June 22, 2018) :Β LUPIN: Lupin closed the week on positive note gaining around 12.70%....